NURS 5334 DIABETES MELLITUS CASE STUDY
NURS 5334 DIABETES MELLITUS CASE STUDY 1
Diabetes Mellitus Case Study
The University of Texas at Arlington
College of Nursing and Health Innovation
In partial fulfillment of the requirements of
Advanced Pharmacology (NURS 5334)
Mary Davis, DNP, MSN, ANP-BC, ADM-BC
, DIABETES MELLITUS CASE STUDY 2
5334 CASE SUMMARY TABLE
• Symptoms: List two pertinent signs and symptoms or risk factors
• The patient’s risk factors for diabetes mellitus are: advanced age > 65 years, central
obesity with BMI > 25, hypertension, dyslipidemia, and a family history of diabetes
(Brashers, Jones, & Huether, 2014, p. 739).
• Symptoms of diabetes mellitus present in patient include blurred vision, fatigue,
polydipsia, polyphagia, and weakness. This patient presents with common physical
symptoms and corresponding lab values confirming diabetes mellitus, random
glucose 202 mg/dL, A1C 7.8%, total cholesterol 280 mg/dL, HDL 27 mg/dL, and
LDL 193 mg/dL (Wells, Schwinghammer, DiPiro, & DiPiro, 2017, p. 172-173).
• Recommended Drugs:
List three recommended drugs as indicated for this diagnosis
1. Metformin (Vallerand, Sanoski, Deglin, 2013, p. 830)
2. Repaglinide (Prandin) (Vallerand et al., 2013, p. 1097)
3. Glipizide (Glucotrol) (Vallerand et al., 2013, p. 1168)
• Drug Categories and Subcategories:
Identify the category of each recommended drug
1. Metformin Category: Antidiabetic; Subcategory: Biguanide (Vallerand et al.,
2013, p. 831)
2. Repaglinide (Prandin) Category: Antidiabetic; Subcategory: meglitinides
(Vallerand et al., 2013, p. 1097)
3. Glipizide (Glucotrol) Category: Antidiabetic; Subcategory: Sulfonylurea
(Vallerand et al., 2013, p. 1168)
Choose medication from the above three recommended drugs to treat identified
disease
Metformin
• Rationale
Provide rationale, clinical guidelines, or evidence for the one selected as drug of choice
NURS 5334 DIABETES MELLITUS CASE STUDY 1
Diabetes Mellitus Case Study
The University of Texas at Arlington
College of Nursing and Health Innovation
In partial fulfillment of the requirements of
Advanced Pharmacology (NURS 5334)
Mary Davis, DNP, MSN, ANP-BC, ADM-BC
, DIABETES MELLITUS CASE STUDY 2
5334 CASE SUMMARY TABLE
• Symptoms: List two pertinent signs and symptoms or risk factors
• The patient’s risk factors for diabetes mellitus are: advanced age > 65 years, central
obesity with BMI > 25, hypertension, dyslipidemia, and a family history of diabetes
(Brashers, Jones, & Huether, 2014, p. 739).
• Symptoms of diabetes mellitus present in patient include blurred vision, fatigue,
polydipsia, polyphagia, and weakness. This patient presents with common physical
symptoms and corresponding lab values confirming diabetes mellitus, random
glucose 202 mg/dL, A1C 7.8%, total cholesterol 280 mg/dL, HDL 27 mg/dL, and
LDL 193 mg/dL (Wells, Schwinghammer, DiPiro, & DiPiro, 2017, p. 172-173).
• Recommended Drugs:
List three recommended drugs as indicated for this diagnosis
1. Metformin (Vallerand, Sanoski, Deglin, 2013, p. 830)
2. Repaglinide (Prandin) (Vallerand et al., 2013, p. 1097)
3. Glipizide (Glucotrol) (Vallerand et al., 2013, p. 1168)
• Drug Categories and Subcategories:
Identify the category of each recommended drug
1. Metformin Category: Antidiabetic; Subcategory: Biguanide (Vallerand et al.,
2013, p. 831)
2. Repaglinide (Prandin) Category: Antidiabetic; Subcategory: meglitinides
(Vallerand et al., 2013, p. 1097)
3. Glipizide (Glucotrol) Category: Antidiabetic; Subcategory: Sulfonylurea
(Vallerand et al., 2013, p. 1168)
Choose medication from the above three recommended drugs to treat identified
disease
Metformin
• Rationale
Provide rationale, clinical guidelines, or evidence for the one selected as drug of choice
